New drugs in the treatment of pituitary disorders.
Because of the poor results and the morbidity associated with surgical and radiation treatment of pituitary adenomas, investigators continue to search for new pharmacologic tools to treat anterior pituitary hyperfunction. New drugs are being studied in the treatment of acromegaly, Cushing's disease, and galactorrhea-amenorrhea, infertility, and impotence associated with prolactin-secreting pituitary tumors.
D000236:Adenoma / Q000150:complications / Q000188:drug therapy*; D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D007172:Erectile Dysfunction / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007989:Libido / Q000187:drug effects; D008297:Male; D010900:Pituitary Diseases / Q000188:drug therapy*; D010904:Pituitary Gland, Posterior / Q000502:physiology; D010905:Pituitary Hormone Release Inhibiting Hormones / Q000627:therapeutic use*; D010906:Pituitary Hormone-Releasing Hormones / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications / Q000188:drug therapy*; D013268:Stimulation, Chemical; D014786:Vision Disorders / Q000188:drug therapy / Q000209:etiology
D010905:Pituitary Hormone Release Inhibiting Hormones; D010906:Pituitary Hormone-Releasing Hormones; D001971:Bromocriptine